Ledger.Open graph →
SEC Form D · Amendment · filed February 8, 2016

Genomind, Inc

Offering
$19.8M
Sold
$15.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
King of Prussia, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Theresa E. Sexton · Nashville, TNDirectorStephen E. Haller · Norfolk, VAExecGloria E. Nuss · Norfolk, VAExecJohn E. Chadwick · Nashville, TNDirectorThomas E. Hess · King of Prussia, PAExecJoseph E. Anton · Boston, MADirectorBeth E. Dozoretz · Norfolk, VAExec · DirectorRonald I. Dozoretz · Norfolk, VAExec · Director · PromoterMichael I. Koffler · King of Prussia, PAExec · Director · PromoterRina E. Wolf · Valencia, CADirectorPhalanx Capital GP, LLC · Chicago, ILExec · DirectorPCM Capital Select Managers Fund LLC · Kansas City, MODirectorR. L. Priest, Jr · Williamsburg, VADirectorRail-Splitter Capital Management, LLC · Chicago, ILDirectorHoward S. Silverman · OMAHA, NEExec · Director · PromoterRobert A. Dean · OMAHA, NEExec · DirectorDouglas L. Dethy · New York, NYExec · DirectorDouglas B. Dunn · Houston, TXExec · Director · PromoterPCM Capital Managed Equity Fund I LLC · Kansas City, MOExec · Director · PromoterAugusto Alvarez · Santa Fe, O5ExecDavid Riker · New York, NYDirectorJack Weiss · New York, NYExec · Director · PromoterJonathan Budd · DEL MAR, CAExecDan A. Westbrook · Oklahoma City, OKDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗